Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 13 results for "claris lifesciences"

Claris Lifesciences rises 3% as RBI allows FPIs to raise stake to 49%
Money Control

Claris Lifesciences rises 3% as RBI allows FPIs to raise stake...

Foreign Portfolios Investors investment limit under Portfolio Investment Scheme in Claris Lifesciences has increased from 24 percent to 49 percent of its paid up capital. Money Control, 4 days ago

4 images for claris lifesciences

Money Control, 4 days ago
Money Control, 4 days ago
Money Control, 1 week ago
Money Control, 4 months ago
Money Control

Claris studying options to distribute Rs 2,077 cr to its shareholders

Shares of Claris Lifesciences today closed at Rs 335.70 on the BSE
 Business Standard1 week ago Claris Lifesciences net cash stands at Rs 381 per share, stock down 7.46%  Money Control1 week ago Claris mulls options to give Rs 2,077 cr to shareholders  Business Standard1 week ago

Claris completes sale of its remaining 20% stake in Otsuka JV for Rs 130 cr

Ahmedabad-headquartered injectables player Claris Lifesciences has completed the sale of its remaining 20 per cent stake in Otsuka Pharmaceutical India Private Ltd (OPIPL), the joint venture with Otsuka Pharmaceutical Factory Inc and Mitsui & Co Ltd, to ...
 Business Standard1 month ago Claris completes USD 20 mn stake sale in JV to Otsuka  Business Standard1 month ago

Claris Lifesciences loses 5% as US FDA issues 18 observations at Ahmedabad plant

The site was inspected by the US drug regulatory between July 27 and August 4, 2017.
 Money Control2 months ago US FDA conducts surprise audit at Claris Life#39;s Ahmedabad unit  Money Control2 months ago

Top buzzing midcap stocks to trade on August 9

Here are a few top buzzing midcap stocks picked by CNBC-TV18#39;s analysts in trade today -- Claris Lifesciences, SRF, Sun Pharmaceutical, JSPL, HDIL, Kaveri Seeds, Nalco, and NMDC.
 Money Control2 months ago

Claris completes sale of global injectables biz to Baxter

Claris Lifesciences has completed the sale of its global generic injectables business to US- based Baxter International Inc for USD 625 million.
 DNA2 months ago

Global Markets Steady Despite North Korea Threat

Posted by Equitymaster Global financial markets ended the week on a flat note despite North Korea once again threatening to test a hydrogen bomb in the Pacific Ocean. The US Federal reserve signaled in its meeting on Wednesday last week that it might raise ...
 Equitymaster.com4 weeks ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less